The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

Correction for DiDomenico et al., Ann Pharmacother 38 (4) 649-660.

Published Online, 27 April 2004, www.theannals.com, DOI 10.1345/aph.1D481a.
 The Annals of Pharmacotherapy: Vol. 38, No. 6, pp. 1090. DOI 10.1345/aph.1D481a
© 2004 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schumock, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schumock, G.

Correction: guidelines for acute decompensated heart failure treatment

Glen Schumock, PharmD MBA FCCP

Director Center for Pharmaceutical Research University of Illinois at Chicago 833 South Wood Street (M/C 886) Chicago, Illinois 60612-7230 fax 312/996-0379 schumock{at}uic.edu

Published Online, April 27, 2004. www.theannals.com, DOI 10.1345/aph.1D481a

TO THE EDITOR: In Table 1 of the article on guidelines for acute decompensated heart failure treatment,1 titration after the first dosage adjustment of nesiritide should occur every 3 hours, not every hour. Likewise, in Figure 3, the infusion rate after the first dosage of nesiritide may be increased every 3 hours, not every hour.

Footnotes

Letters are subject to review prior to acceptance. They should address areas related to pharmacy practice, research, or education, or articles recently published. Corrections of previously published material also are accepted. Letters are limited to no more than five authors. In cases where adverse drug effects are described, the Naranjo ADR probability scale should be used to determine the likelihood that the adverse effect was drug-related (Clin Pharmacol Ther 1981;30:239-45). Text: limit 500 words. References: limit 5. Art: limit 1 table or figure.

References

  1. DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, et al. Guidelines for acute decompensated heart failure treatment.Ann Pharmacother 2004;38:649-60. DOI 10.1345/aph.1D481[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
R. J DiDomenico, A. Perez, H. M Schumann, D. R Fontana, G. T Kondos, and G. T Schumock
Impact of Treatment Guidelines on Clinical and Economic Outcomes of Acute Decompensated Heart Failure
Ann. Pharmacother., March 1, 2008; 42(3): 327 - 333.
[Abstract] [Full Text] [PDF]

This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schumock, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schumock, G.

homecopy help contact us subscription past issues search current issue